#htmlcaption1 #htmlcaption2 #htmlcaption3 #htmlcaption4

ABOUT ALLERGAN

Dedicated to Continuous Innovation for Your Well-Being


Global in reach. Specialised in focus.

On March 17th, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma.  The combined company has broad commercial reach extending across approximately 100 countries and is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team.

ALLERGAN UK

Allergan Limited
Marlow International
The Parkway
MARLOW Buckinghamshire
SL7 1YL
UK

Phone: +44(0)1628 494444
Fax: +44(0)1628 494449